Zoetis Inc. Increase (Decrease) in Operating Capital
Zoetis Inc. (ZTS) reported Increase (Decrease) in Operating Capital of $165.00 million for the 3-month period ending 2015-03-29, per its 10-Q filed 2015-05-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2015-05-07
- Zoetis Inc. increase (decrease) in operating capital for the quarter ending 2015-03-29 was $165.00M, a 30.67% decline year-over-year.
- Zoetis Inc. increase (decrease) in operating capital for the quarter ending 2014-09-28 was $75.00M, a 59.57% increase year-over-year.
- Zoetis Inc. increase (decrease) in operating capital for the quarter ending 2014-06-29 was $24.00M, a 86.89% decline year-over-year.
- Zoetis Inc. increase (decrease) in operating capital for the quarter ending 2014-03-30 was $238.00M.
| Period end | Increase (Decrease) in Operating Capital 3 month | Increase (Decrease) in Operating Capital 6 month | Increase (Decrease) in Operating Capital 9 month |
|---|---|---|---|
| 2015-03-29 | $165.00M 10-Q · filed 2015-05-07 | ||
| 2014-09-28 | $75.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $99.00M derived: sum of 2 quarters · filed 2014-11-10 | $337.00M 10-Q · filed 2014-11-10 |
| 2014-06-29 | $24.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $262.00M 10-Q · filed 2014-08-12 | |
| 2014-03-30 | $238.00M 10-Q · filed 2015-05-07 | ||
| 2013-09-29 | $47.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $230.00M derived: sum of 2 quarters · filed 2014-11-10 | $162.00M 10-Q · filed 2014-11-10 |
| 2013-06-30 | $183.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $115.00M 10-Q · filed 2014-08-12 | |
| 2013-03-31 | -$68.00M 10-Q · filed 2014-05-13 | ||
| 2012-09-30 | $96.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $239.00M derived: sum of 2 quarters · filed 2013-11-13 | $402.00M 10-Q · filed 2013-11-13 |
| 2012-07-01 | $143.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $306.00M 10-Q · filed 2013-08-14 | |
| 2012-04-01 | $163.00M 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |